Obesity strategy should not be built around a single drug Tirzepatide (Mounjaro) has had a remarkable journey to prominence since its UK marketing authorisation in 2023.1 Approved for glycaemic ...

As a doctor with lived experience of an eating disorder, I know that there is a huge amount we can do to educate ourselves better about eating disorders to improve patient care and experiences, writes ...

McCartney makes many cogent, well argued points about how potential legislation as a result of a private member’s success is essentially a lottery.1 Like it or not, this is our parliamentary system, ...

Andrew studied medicine at Clare College, Cambridge, and St Thomas’ Hospital, London. After house jobs he did national service in Malta and then moved to Edenbridge, Kent, in 1957. Here he worked as a ...

Doctors were left feeling angry and unsupported after NHS leaders failed to take the threat of racism and Islamophobia seriously. Annabel Sowemimo and Zosia Kmietowicz report Last summer an estimated ...

The government’s efforts to tackle antimicrobial resistance (AMR) have had limited impact, the National Audit Office (NAO) has warned. Despite taking the threat seriously, resistant infections have ...

It’s hard to ignore Donald Trump and the deep harm he’s inflicting on health, both in the US and worldwide (doi:10.1136/bmj.r370 doi:10.1136/bmj.r357 doi:10.1136/bmj.r356 doi:10.1136/bmj.r279 ...

An anonymous scientist updates on the situation in the US I work inside the US federal research system and The BMJ allowed me to publish an anonymous account of how science and certain populations are ...

Health authorities have yet to identify the cause of outbreaks of a disease in the Democratic Republic of Congo that the World Health Organization has called “a significant public health threat.” Last ...

Aid organisations have expressed horror at the UK government’s decision to slash spending on overseas development in order to fund an increase in the defence budget. On 25 February UK prime minister ...

Institutions must value patient partners in research with fair and transparent compensation policies, or their commitments to equity will be hollow, write Amy Price and Dawn P Richards A conflict ...